Established in 2022, eMyosound is developing a groundbreaking non-invasive solution for the assessment of cardiac diseases. Founded from the Physics for Medicine Paris laboratory (INSERM, CNRS, ESPCI PSL Paris), their company is dedicated to advancing the field of cardiology by leveraging the power of ultrasound elastography and shear wave technology.